The Morrison government is committing $1 billion to safeguard Australia's access to vaccines

The federal government has struck a $1 billion deal to safeguard Australia's long-term access to flu and fever vaccines, as well as life-saving antivenoms.

Prime Minister Scott Morrison.

Scott Morrison used a G20 speech to talk up Australia's track record on emissions reduction. Source: AAP

A new flu vaccine manufacturing plant will be built in Melbourne to guard against future pandemics and provide antivenoms for some of Australia's most deadly creatures.

The federal government has struck a $1 billion, 12-year deal with CSL subsidiary Seqirus for long-term access to influenza and fever vaccines.

The company will invest $800 million to develop a hi-tech vaccine manufacturing facility near Melbourne airport to replace its more than 60-year-old Parkville site.
Prime Minister Scott Morrison said the agreement built on CSL's efforts to manufacture coronavirus vaccine candidates, which started last week.

"It is about the production of Aussie doses of the COVID-19 vaccine," he told reporters on Monday.

Mr Morrison said vaccine manufacturing capabilities would be crucial in the event of another pandemic.

"This has been a common discussion amongst like-minded countries around the world... the need for us to do even more to secure supply changes in critical areas," he said.

"There could be few more critical than those that apply to vaccines."
A high-tech vaccine manufacturing facility will be developed near Melbourne airport to replace its more than 60-year-old Parkville site.
A high-tech vaccine manufacturing facility will be developed near Melbourne airport to replace its more than 60-year-old Parkville site. Source: AAP
Health Minister Greg Hunt said the anti-venoms could be used for taipans, tiger snakes, brown snakes, box jellyfish and stonefish.

"It is like a roll call of Australiana," he said.

Work on the plant will start next year with the site expected to be operating by mid-2026 and more than 500 jobs expected to be created.

The existing deal with Seqirus was due to expire in 2024/25, potentially putting Australia at risk of needing to source critical medical products from overseas.

The new agreement runs until 2036.

Seqirus is the only company that makes influenza and Q fever vaccines in Australia, while no other firm in the world produces life-saving antivenoms against 11 poisonous Australian snakes, marine creatures and spiders.

People in Australia must stay at least 1.5 metres away from others. Check your jurisdiction's restrictions on gathering limits.

If you are experiencing cold or flu symptoms, stay home and arrange a test by calling your doctor or contact the Coronavirus Health Information Hotline on 1800 020 080.

News and information is available in 63 languages at 

Please check the relevant guidelines for your state or territory: 


Share
2 min read
Published 16 November 2020 5:34am
Updated 16 November 2020 12:35pm
Source: AAP, SBS



Share this with family and friends